Trials / Conditions / Refractory Plasma Cell Neoplasm
Refractory Plasma Cell Neoplasm
3 registered clinical trials studyying Refractory Plasma Cell Neoplasm.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Vaccine Therapy in Treating Patients With Multiple Myeloma NCT00019097 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma NCT00112879 | The Cleveland Clinic | Phase 2 |
| Withdrawn | Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myelo NCT00085345 | Oncotherapeutics | Phase 2 |